Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

HealthcareLtd Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Zhang Gen Ni

İcra Kurulu Başkanı

CN¥804.8k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	12yrs
CEO sahipliği	34.0%
Yönetim ortalama görev süresi	12yrs
Yönetim Kurulu ortalama görev süresi	10.2yrs

Son yönetim güncellemeleri

Recent updates

Market Participants Recognise Healthcare Co.,Ltd.'s (SHSE:603313) Earnings

Sep 26

HealthcareLtd's (SHSE:603313) Profits Appear To Have Quality Issues

Sep 06

CEO

Zhang Gen Ni (49 yo)

12yrs

Görev süresi

CN¥804,800

Tazminat

Mr. Zhang Gen Ni is Chairman of the Board & President of Healthcare Co., Ltd. since October 29, 2012. He was Chairman of the Board, General Manager and Director of Development Center of Healthcare Co., Ltd...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhang Gen Ni	Chairman of the Board & President	12yrs	CN¥804.80k	33.97% CN¥ 1.4b
Xiao Hong Wu	VP & Director	12yrs	CN¥441.40k	0.0053% CN¥ 215.3k
Hong Jian Zhang	VP & Director	12yrs	CN¥710.30k	0.0053% CN¥ 215.3k
Hailong Zhang	Accounting Supervisor	no data	Veri yok	Veri yok

12.0yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: 603313's management team is seasoned and experienced (12 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhang Gen Ni	Chairman of the Board & President	12yrs	CN¥804.80k	33.97% CN¥ 1.4b
Xiao Hong Wu	VP & Director	12yrs	CN¥441.40k	0.0053% CN¥ 215.3k
Hong Jian Zhang	VP & Director	12yrs	CN¥710.30k	0.0053% CN¥ 215.3k
Jian Long Ji	Director	8.4yrs	CN¥474.10k	0.0053% CN¥ 215.3k
Tao Lin	Employee Supervisor	12yrs	Veri yok	Veri yok
Hua Wei	Member of Supervisory Board	12yrs	Veri yok	Veri yok
Chang Ling Zhu	Independent Director	5.5yrs	CN¥80.00k	Veri yok
Baiming Xu	Independent Director	5.5yrs	CN¥80.00k	Veri yok
Zaifa Cai	Independent Director	5.5yrs	CN¥80.00k	Veri yok
Jian Sun	Chairman of the Supervisory Board	7.8yrs	Veri yok	Veri yok

10.2yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 603313's board of directors are seasoned and experienced ( 10.2 years average tenure).

HealthcareLtd Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Healthcare Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 18%

Market Participants Recognise Healthcare Co.,Ltd.'s (SHSE:603313) Earnings

Price target decreased by 60% to CN¥5.30

HealthcareLtd's (SHSE:603313) Profits Appear To Have Quality Issues

Second quarter 2024 earnings released: EPS: CN¥0.065 (vs CN¥0.19 in 2Q 2023)

Now 22% overvalued

Healthcare Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd., Annual General Meeting, May 17, 2024

Healthcare Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Shareholder dilution

Healthcare Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial position

Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.03 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.11 in 2Q 2022)

Now 20% undervalued

Price target decreased by 10% to CN¥12.68

First quarter 2023 earnings released: EPS: CN¥0.03 (vs CN¥0.06 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.59 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.12 loss in 2Q 2021)

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CN¥15.00

Less than half of directors are independent

Third quarter 2021 earnings released: CN¥0.59 loss per share (vs CN¥0.42 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Price target decreased to CN¥29.93

Second quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.17 profit in 2Q 2020)

Investor sentiment deteriorated over the past week

Price target decreased to CN¥28.03

Price target increased to CN¥52.73

Full year 2020 earnings released: EPS CN¥1.11 (vs CN¥1.18 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥43.05

New 90-day high: CN¥39.17

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: CN¥36.87

Price target raised to CN¥46.61

Analysts update estimates

Healthcare Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

Third quarter earnings released

Price target raised to CN¥36.16

Earnings released

New 90-day high - CN¥29.33

New 90-day high - CN¥26.83

Healthcare Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş